- Filed
- Sep 13, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Aug 31, 2021 | 28.05M sh |
| Stock Issued | Q3 2021 · Jul 31, 2021 | 30K sh |
| Stock Issued | Q3 2021 · Oct 31, 2019 | 183.74K sh |
| Operating Cash Flow | Q3 2021 · Jul 31, 2021 | −$86.37K |
| Operating Cash Flow | Q3 2021 · Jul 31, 2020 | −$76.42K |
| Cash And Equivalents | Q3 2021 · Jul 31, 2021 | $60 |
| Cash And Equivalents | Q3 2021 · Oct 31, 2020 | $21 |
| Stockholders Equity | Q3 2021 · Jul 31, 2021 | $788.37K |
| Stockholders Equity | Q3 2021 · Jul 31, 2019 | −$58.53K |
| Current Liabilities | Q3 2021 · Jul 31, 2021 | $241.74K |
| Current Liabilities | Q3 2021 · Oct 31, 2020 | $239K |
| Total Liabilities | Q3 2021 · Jul 31, 2021 | $241.74K |
| Total Liabilities | Q3 2021 · Oct 31, 2020 | $239K |
| Current Assets | Q3 2021 · Jul 31, 2021 | $60 |
| Current Assets | Q3 2021 · Oct 31, 2020 | $21 |
| Total Assets | Q3 2021 · Jul 31, 2021 | $1.03M |
| Total Assets | Q3 2021 · Oct 31, 2020 | $1.03M |
| Operating Income | Q3 2021 · Jul 31, 2021 | $59.83K |
| Operating Income | Q3 2021 · Jul 31, 2021 | $72.84K |
| Operating Income restated | Q3 2021 · Jul 31, 2020 | $67.81K |
| Operating Income restated | Q3 2021 · Jul 31, 2020 | $339.6K |
| Capex | Q3 2021 · Jul 31, 2020 | $105K |
| Net Income | Q3 2021 · Apr 30, 2020 | −$185.13K |
| Net Income | Q3 2021 · Jan 31, 2020 | −$86.66K |
| Net Income | Q3 2021 · Oct 31, 2019 | −$95.79K |